Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-19 Purchase | 2021-11-23 07:30 am | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 3,950 | $37.3 | $147,350 | 167,668 (Indirect Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 07:31 am | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 955 | $35.26 | $33,676 | 41,931 (Indirect Direct) | View |
| 2021-11-18 Purchase | 2021-11-22 07:30 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,430 | $35.09 | $50,181 | 426,528 (Indirect Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 07:30 am | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 3,300 | $34.52 | $113,922 | 10,102 (Indirect Direct) | View |
| 2021-05-12 Purchase | 2021-05-13 07:05 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 500 | $58.15 | $29,075 | 425,098 (Indirect Direct) | View |
| 2020-06-29 Purchase | 2020-06-30 08:20 am | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 650 | $78.5 | $51,025 | 408,798 (Indirect Direct) | View |
| 2020-06-29 Purchase | 2020-06-30 08:19 am | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 777 | $76.64 | $59,549 | 41,277 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Option Award | 2023-03-06 6:13 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,082 | $0 | 2,082 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 6:12 pm | 2023-03-02 2033-03-01 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 2,224 | $0 | 2,224 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $0 | 447,525 (Direct) | View |
| 2023-01-03 Exercise | 2023-01-04 4:11 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 17,501 | $1.3 | 447,525 (Direct) | View |
Ownership | 2022-06-15 4:31 pm | N/A 2031-12-13 | Axsome Therapeutics Inc. | AXSM | Murdock Hunter R. General Counsel | 0 | $0 | 142,335 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:08 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 4:07 pm | 2023-06-03 2032-06-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 16,976 | $0 | 16,976 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | 2013-03-22 2023-03-21 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $0 | 447,525 (Direct) | View |
| 2022-03-15 Exercise | 2022-03-17 07:05 am | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 3,496 | $1.3 | 447,525 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:04 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 320,516 | $0 | 320,516 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:03 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 137,395 | $0 | 137,395 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:02 pm | N/A 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 119,048 | $0 | 119,048 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 2,798 | $0 | 2,798 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 2,347 | $0 | 2,347 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 5:00 pm | 2022-03-04 2032-03-03 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 2,337 | $0 | 2,337 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-15 7:55 pm | N/A 2031-11-11 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick CHIEF FINANCIAL OFFICER | 36,086 | $0 | 36,086 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-15 7:54 pm | N/A 2031-11-11 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. CHIEF OPERATING OFFICER | 41,638 | $0 | 41,638 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:52 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 7,325 | $0 | 7,325 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:52 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 7,325 | $0 | 7,325 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:51 pm | 2022-06-04 2031-06-04 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 7,325 | $0 | 7,325 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:48 pm | N/A 2031-03-04 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 55,294 | $0 | 55,294 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:47 pm | 2021-03-05 2031-03-04 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 1,241 | $0 | 1,241 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:46 pm | N/A 2031-03-04 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 63,801 | $0 | 63,801 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:45 pm | N/A 2031-03-04 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 148,870 | $0 | 148,870 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:45 pm | 2021-03-05 2031-03-04 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 1,201 | $0 | 1,201 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-09 9:45 pm | 2021-03-05 2031-03-04 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 1,463 | $0 | 1,463 (Direct) | View |
| 2020-03-17 Option Award(A) | 2020-12-23 6:08 pm | N/A 2030-03-16 | Axsome Therapeutics Inc. | AXSM | Jacobson Mark L. Chief Operating Officer | 63,004 | $0 | 63,004 (Direct) | View |
| 2020-03-17 Option Award(A) | 2020-12-23 6:08 pm | N/A 2030-03-16 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 63,004 | $0 | 63,004 (Direct) | View |
| 2020-08-19 Gift | 2020-08-20 8:43 pm | N/A N/A | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 397,998 | $0 | 408,798 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-05 6:42 pm | 2021-06-05 2030-06-05 | Axsome Therapeutics Inc. | AXSM | Saad Mark E Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-05 6:41 pm | 2021-06-05 2030-06-05 | Axsome Therapeutics Inc. | AXSM | JEFFS ROGER Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-05 6:40 pm | 2021-06-05 2030-06-05 | Axsome Therapeutics Inc. | AXSM | Coleman Mark Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 9:20 pm | N/A 2030-03-16 | Axsome Therapeutics Inc. | AXSM | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 10% Owner | 220,467 | $0 | 220,467 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 9:19 pm | N/A 2030-03-16 | Axsome Therapeutics Inc. | AXSM | Pizzie Nick Chief Financial Officer | 79,525 | $0 | 79,525 (Direct) | View |